Revisiting the role of CD4+ T cells in cancer immunotherapy—new insights into old paradigms
出版年份 2020 全文链接
标题
Revisiting the role of CD4+ T cells in cancer immunotherapy—new insights into old paradigms
作者
关键词
-
出版物
CANCER GENE THERAPY
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-05-27
DOI
10.1038/s41417-020-0183-x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Regulatory T Cell Development
- (2020) Peter A. Savage et al. Annual Review of Immunology
- Regulatory T Cells Restrain Interleukin-2- and Blimp-1-Dependent Acquisition of Cytotoxic Function by CD4+ T Cells
- (2020) Anna Śledzińska et al. IMMUNITY
- Turning the Tide Against Regulatory T Cells
- (2019) SeongJun Han et al. Frontiers in Oncology
- Distinct prognostic value of circulating anti-telomerase CD4+ Th1 immunity and exhausted PD-1+/TIM-3+ T cells in lung cancer
- (2019) Caroline Laheurte et al. BRITISH JOURNAL OF CANCER
- Advances in cancer immunotherapy 2019 – latest trends
- (2019) Stephan Kruger et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- The Tolerogenic Function of Regulatory T Cells in Pregnancy and Cancer
- (2019) Nanna Jørgensen et al. Frontiers in Immunology
- Single-cell Analysis of CAR-T Cell Activation Reveals A Mixed TH1/TH2 Response Independent of Differentiation
- (2019) Iva Xhangolli et al. GENOMICS PROTEOMICS & BIOINFORMATICS
- A Phase I Study of the Anti-CC Chemokine Receptor 4 Antibody, Mogamulizumab, in Combination with Nivolumab in Patients with Advanced or Metastatic Solid Tumors
- (2019) Toshihiko Doi et al. CLINICAL CANCER RESEARCH
- MHC Class II Antigen Presentation by the Intestinal Epithelium Initiates Graft-versus-Host Disease and Is Influenced by the Microbiota
- (2019) Motoko Koyama et al. IMMUNITY
- CD4 T cells target colorectal cancer antigens upregulated by oxaliplatin
- (2019) Jeanne Galaine et al. INTERNATIONAL JOURNAL OF CANCER
- Blockade of PD-L1 Enhances Cancer Immunotherapy by Regulating Dendritic Cell Maturation and Macrophage Polarization
- (2019) Nai-Yun Sun et al. Cancers
- Regulatory T Cell Development in the Thymus
- (2019) David L. Owen et al. JOURNAL OF IMMUNOLOGY
- MHC-II neoantigens shape tumour immunity and response to immunotherapy
- (2019) Elise Alspach et al. NATURE
- CD4+ T Cell Help Is Required for the Formation of a Cytolytic CD8+ T Cell Subset that Protects against Chronic Infection and Cancer
- (2019) Ryan Zander et al. IMMUNITY
- CD4+ T-cell Immunity in the Peripheral Blood Correlates with Response to Anti-PD-1 Therapy
- (2019) Hiroshi Kagamu et al. Cancer Immunology Research
- Regulatory T cells: a potential target in cancer immunotherapy
- (2018) Kohei Shitara et al. Annals of the New York Academy of Sciences
- Emerging Concepts for Immune Checkpoint Blockade-Based Combination Therapies
- (2018) Roberta Zappasodi et al. CANCER CELL
- T-bet promotes potent antitumor activity of CD4+ CAR T cells
- (2018) Albert T Gacerez et al. CANCER GENE THERAPY
- A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy
- (2018) Xuexiang Du et al. CELL RESEARCH
- Oncolytic Virus Combination Therapy: Killing One Bird with Two Stones
- (2018) Nikolas Tim Martin et al. MOLECULAR THERAPY
- Comparative transcriptome analysis reveals distinct genetic modules associated with Helios expression in intratumoral regulatory T cells
- (2018) Kathleen Yates et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cancer immunotherapy using checkpoint blockade
- (2018) Antoni Ribas et al. SCIENCE
- Eradication of spontaneous malignancy by local immunotherapy
- (2018) Idit Sagiv-Barfi et al. Science Translational Medicine
- MHC proteins confer differential sensitivity to CTLA-4 and PD-1 blockade in untreated metastatic melanoma
- (2018) Scott J. Rodig et al. Science Translational Medicine
- OX40 Costimulation Inhibits Foxp3 Expression and Treg Induction via BATF3-Dependent and Independent Mechanisms
- (2018) Xiaolong Zhang et al. Cell Reports
- Targeting EZH2 Reprograms Intratumoral Regulatory T Cells to Enhance Cancer Immunity
- (2018) David Wang et al. Cell Reports
- Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations
- (2018) Jun Gong et al. Journal for ImmunoTherapy of Cancer
- Not All Immune Checkpoints Are Created Equal
- (2018) Annika De Sousa Linhares et al. Frontiers in Immunology
- Epithelial MHC Class II Expression and Its Role in Antigen Presentation in the Gastrointestinal and Respiratory Tracts
- (2018) Jonathan E. Wosen et al. Frontiers in Immunology
- Long-peptide vaccination with driver gene mutations in p53 and Kras induces cancer mutation-specific effector as well as regulatory T cell responses
- (2018) Jasmin Quandt et al. OncoImmunology
- New Hope for Therapeutic Cancer Vaccines in the Era of Immune Checkpoint Modulation
- (2018) Michael A. Curran et al. Annual Review of Medicine
- Biological Consequences of Major Histocompatibility Class-II Expression by Tumor Cells in Cancer
- (2018) Margaret L Axelrod et al. CLINICAL CANCER RESEARCH
- Lineage tracking reveals dynamic relationships of T cells in colorectal cancer
- (2018) Lei Zhang et al. NATURE
- Regulatory T cells in the treatment of disease
- (2018) Amir Sharabi et al. NATURE REVIEWS DRUG DISCOVERY
- Expanding the Therapeutic Window for CAR T Cell Therapy in Solid Tumors: The Knowns and Unknowns of CAR T Cell Biology
- (2018) Keisuke Watanabe et al. Frontiers in Immunology
- CD4 + T Cell Help Confers a Cytotoxic T Cell Effector Program Including Coinhibitory Receptor Downregulation and Increased Tissue Invasiveness
- (2017) Tomasz Ahrends et al. IMMUNITY
- Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
- (2017) Ugur Sahin et al. NATURE
- An immunogenic personal neoantigen vaccine for patients with melanoma
- (2017) Patrick A. Ott et al. NATURE
- TCR engagement negatively affects CD8 but not CD4 CAR T cell expansion and leukemic clearance
- (2017) Yinmeng Yang et al. Science Translational Medicine
- Combination immunotherapy: a road map
- (2017) Patrick A. Ott et al. Journal for ImmunoTherapy of Cancer
- Turning tumour cells into antigen presenting cells: The next step to improve cancer immunotherapy?
- (2016) Marie de Charette et al. EUROPEAN JOURNAL OF CANCER
- Tertiary lymphoid structures, drivers of the anti-tumor responses in human cancers
- (2016) Marie-Caroline Dieu-Nosjean et al. IMMUNOLOGICAL REVIEWS
- Chimeric antigen receptor-modified T cells strike back
- (2016) Matthew J. Frigault et al. INTERNATIONAL IMMUNOLOGY
- Antigen-presenting epithelial cells can play a pivotal role in airway allergy
- (2016) Julia Arebro et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- The immune system and cancer evasion strategies: therapeutic concepts
- (2016) S. Muenst et al. JOURNAL OF INTERNAL MEDICINE
- Two FOXP3+CD4+ T cell subpopulations distinctly control the prognosis of colorectal cancers
- (2016) Takuro Saito et al. NATURE MEDICINE
- Instability of Helios-deficient Tregs is associated with conversion to a T-effector phenotype and enhanced antitumor immunity
- (2016) Hidetoshi Nakagawa et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy
- (2016) Douglas B. Johnson et al. Nature Communications
- Differential Intrasplenic Migration of Dendritic Cell Subsets Tailors Adaptive Immunity
- (2016) Samuele Calabro et al. Cell Reports
- Increased proportion of FoxP3+ regulatory T cells in tumor infiltrating lymphocytes is associated with tumor recurrence and reduced survival in patients with glioblastoma
- (2015) Elias J. Sayour et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Robust Anti-viral Immunity Requires Multiple Distinct T Cell-Dendritic Cell Interactions
- (2015) Sarah Eickhoff et al. CELL
- Vaccination with Melanoma Helper Peptides Induces Antibody Responses Associated with Improved Overall Survival
- (2015) C. M. Reed et al. CLINICAL CANCER RESEARCH
- Spatiotemporally Distinct Interactions with Dendritic Cell Subsets Facilitates CD4+ and CD8+ T Cell Activation to Localized Viral Infection
- (2015) Jyh Liang Hor et al. IMMUNITY
- CD4 + T Cell Tolerance to Tissue-Restricted Self Antigens Is Mediated by Antigen-Specific Regulatory T Cells Rather Than Deletion
- (2015) Francois P. Legoux et al. IMMUNITY
- CRTAM determines the CD4+cytotoxic T lymphocyte lineage
- (2015) Arata Takeuchi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Mutant MHC class II epitopes drive therapeutic immune responses to cancer
- (2015) Sebastian Kreiter et al. NATURE
- Trastuzumab emtansine (T-DM1) renders HER2 + breast cancer highly susceptible to CTLA-4/PD-1 blockade
- (2015) Philipp Müller et al. Science Translational Medicine
- Immune evasion in cancer: Mechanistic basis and therapeutic strategies
- (2015) Dass S. Vinay et al. SEMINARS IN CANCER BIOLOGY
- GITR subverts Foxp3+ Tregs to boost Th9 immunity through regulation of histone acetylation
- (2015) Xiang Xiao et al. Nature Communications
- Direct tumor recognition by a human CD4+ T-cell subset potently mediates tumor growth inhibition and orchestrates anti-tumor immune responses
- (2015) Junko Matsuzaki et al. Scientific Reports
- Survivin-targeted immunotherapy drives robust polyfunctional T cell generation and differentiation in advanced ovarian cancer patients
- (2015) Neil L Berinstein et al. OncoImmunology
- Regulatory T cells in cancer immunotherapy
- (2014) Hiroyoshi Nishikawa et al. CURRENT OPINION IN IMMUNOLOGY
- Shaping the repertoire of tumor-infiltrating effector and regulatory T cells
- (2014) Peter A. Savage et al. IMMUNOLOGICAL REVIEWS
- CD20 alternative splicing isoform generates immunogenic CD4 helper T epitopes
- (2014) Charline Vauchy et al. INTERNATIONAL JOURNAL OF CANCER
- Comprehensive Analysis of HLA-DR- and HLA-DP4-Restricted CD4+ T Cell Response Specific for the Tumor-Shared Antigen Survivin in Healthy Donors and Cancer Patients
- (2014) X.-F. Wang et al. JOURNAL OF IMMUNOLOGY
- High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma
- (2014) Carsten Linnemann et al. NATURE MEDICINE
- Cancer Immunotherapy Based on Mutation-Specific CD4+ T Cells in a Patient with Epithelial Cancer
- (2014) E. Tran et al. SCIENCE
- Perspectives on Reprograming Cancer-Associated Dendritic Cells for Anti-Tumor Therapies
- (2014) Fabian Benencia et al. Frontiers in Oncology
- Chimeric Antigen Receptor Therapy for Cancer
- (2013) David M. Barrett et al. Annual Review of Medicine
- Tumor-specific CD4+T cells maintain effector and memory tumor-specific CD8+T cells
- (2013) Sarah E. Church et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Targeting antitumor CD4 helper T cells with universal tumor-reactive helper peptides derived from telomerase for cancer vaccine
- (2013) Olivier Adotévi et al. Human Vaccines & Immunotherapeutics
- CD4+ T Effectors Specific for the Tumor Antigen NY-ESO-1 Are Highly Enriched at Ovarian Cancer Sites and Coexist with, but Are Distinct from, Tumor-Associated Treg
- (2013) M. Ayyoub et al. Cancer Immunology Research
- Targeting CD4+ T-Helper Cells Improves the Induction of Antitumor Responses in Dendritic Cell-Based Vaccination
- (2012) E. H. J. G. Aarntzen et al. CANCER RESEARCH
- Analysis of Spontaneous Tumor-Specific CD4 T-cell Immunity in Lung Cancer Using Promiscuous HLA-DR Telomerase-Derived Epitopes: Potential Synergistic Effect with Chemotherapy Response
- (2012) Y. Godet et al. CLINICAL CANCER RESEARCH
- Targeting the MHC Class II antigen presentation pathway in cancer immunotherapy
- (2012) Jacques Thibodeau et al. OncoImmunology
- Telomerase Peptide Vaccination in NSCLC: A Phase II Trial in Stage III Patients Vaccinated after Chemoradiotherapy and an 8-Year Update on a Phase I/II Trial
- (2011) P. F. Brunsvig et al. CLINICAL CANCER RESEARCH
- Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy
- (2011) S. A. Rosenberg et al. CLINICAL CANCER RESEARCH
- Spontaneous antibody, and CD4 and CD8 T-cell responses against XAGE-1b (GAGED2a) in non-small cell lung cancer patients
- (2011) Yoshihiro Ohue et al. INTERNATIONAL JOURNAL OF CANCER
- Split T Cell Tolerance against a Self/Tumor Antigen: Spontaneous CD4+ but Not CD8+ T Cell Responses against p53 in Cancer Patients and Healthy Donors
- (2011) Takemasa Tsuji et al. PLoS One
- CD4+ T-Cell Help in the Tumor Milieu Is Required for Recruitment and Cytolytic Function of CD8+ T Lymphocytes
- (2010) R. Bos et al. CANCER RESEARCH
- Analysis of the T-Cell Receptor Repertoires of Tumor-Infiltrating Conventional and Regulatory T Cells Reveals No Evidence for Conversion in Carcinogen-Induced Tumors
- (2010) J. P. Hindley et al. CANCER RESEARCH
- Naive tumor-specific CD4+T cells differentiated in vivo eradicate established melanoma
- (2010) Ying Xie et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Tumor-reactive CD4+T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts
- (2010) Sergio A. Quezada et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Intradermal Vaccinations With RNA Coding for TAA Generate CD8+ and CD4+ Immune Responses and Induce Clinical Benefit in Vaccinated Patients
- (2010) Susanne M Rittig et al. MOLECULAR THERAPY
- The CD4+ T-Cell Response of Melanoma Patients to a MAGE-A3 Peptide Vaccine Involves Potential Regulatory T Cells
- (2009) V. Francois et al. CANCER RESEARCH
- Plasticity of CD4+ T Cell Lineage Differentiation
- (2009) Liang Zhou et al. IMMUNITY
- Antigen-specific Tregs control T cell responses against a limited repertoire of tumor antigens in patients with colorectal carcinoma
- (2009) Andreas Bonertz et al. JOURNAL OF CLINICAL INVESTIGATION
- Concurrent Trastuzumab and HER2/neu-Specific Vaccination in Patients With Metastatic Breast Cancer
- (2009) Mary L. Disis et al. JOURNAL OF CLINICAL ONCOLOGY
- The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans
- (2009) Cameron S. Brandt et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Multiple roles for CD4+T cells in anti-tumor immune responses
- (2008) Richard Kennedy et al. IMMUNOLOGICAL REVIEWS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started